Dr. Olivier Gerbault's Private Practice
Dr. Olivier Gerbault's Private Practice
France, Paris
Immunology cost in France typically averages between $2,300 and $15,000. Prices are influenced by the specific treatment modality, duration of therapy cycles, and whether the patient requires inpatient or outpatient care. Patients can expect 50-65% savings compared to the US for advanced immunological therapies and regenerative procedures.
Typical Immunology Costs in France
Specialized immunology services are primarily centered in Paris and Lyon, where major medical institutes and research hospitals are concentrated. These cities host most international patient programs. Consult with a specialist to get accurate pricing for your specific medical case and therapy requirements.
| France | Turkey | Austria | |
| Umbilical cord stem cell therapy | from $11,000 | from $5,000 | from $7,500 |
| Plasmapheresis | from $1,800 | from $1,200 | from $2,000 |
| Curcumin IV Therapy | from $750 | from $350 | from $350 |
| Therapeutic Apheresis | - | from $1,350 | - |
| Selective Apheresis | - | from $1,550 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Immunology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunology treatment journey.
France treats autoimmune diseases through a network of university hospitals (CHU) and certified reference centers. The national FAI2R network coordinates over 80 expert sites. Leading facilities include Hôpital Cochin and Hôpital Pitié-Salpêtrière in Paris, alongside specialized interdisciplinary hubs in Montpellier and Lyon.
Bookimed Expert Insight: French university hospitals prioritize interdisciplinary care for rare conditions. Data shows specialized centers in Montpellier, like the Immun4Cure institute, integrate research directly into clinical practice. Patients benefit from these academic environments where specialists manage complex diagnostics alongside active clinical trials.
Patient Consensus: Patients recommend using hospital-based care over private clinics for better insurance coverage. They suggest bringing complete medical records to ensure specialists can provide an effective treatment plan.
France manages advanced immunotherapies through a centralized, state-regulated framework. The Haute Autorité de Santé (HAS) provides early access to CAR-T therapies via the AAP system. This mechanism bypasses standard pricing delays for urgent hematological cases. Highly specialized, certified academic centers handle all clinical administration.
Bookimed Expert Insight: French immunology centers utilize a decentralized preparatory model to optimize resource use. While academic hubs handle complex cell engineering, regional partners often manage initial chemotherapy steps. This integration between public labs and regional hospitals maintains high patient volumes without overloading specialized beds.
Patient Consensus: These therapies require intensive hospital stays in large tertiary centers due to potential side effects. Patients note that staying near the facility is vital for monitoring after the infusion process.
France manages CIDP and immune deficiencies through standardized national protocols called PNDS. Treatment utilizes intravenous or subcutaneous immunoglobulins to prevent nerve damage and infections. The national health system typically covers these essential therapies. Specialized hospital reference centers oversee prescription safety and product traceability.
Bookimed Expert Insight: French immunology centers prioritize transitioning stable patients to subcutaneous SCIg therapy. This shift typically reduces hospital visits while maintaining steady IgG serum levels. Our data shows that initial consultations for treatment planning in France range from Price on request to Price on request .
Patient Consensus: Patients note that immunoglobulin therapy is a long-term commitment rather than a quick cure. Many emphasize that keeping a strict infusion schedule is vital to prevent weakness from returning between doses.
Allergen immunotherapy is a primary treatment for respiratory allergies and venom hypersensitivity in France. The national health system, Assurance Maladie, routinely covers these desensitization protocols. Specialists favor sublingual methods for safety. Patients typically combine public coverage with private insurance to manage costs.
Bookimed Expert Insight: Immunology consultations in France start from Price on request . While the system is supportive, international patients should note that reimbursement depends on social security enrollment. Public coverage is not automatic for new arrivals. We recommend bringing detailed records to match specific allergen molecules available locally.
Patient Consensus: Patients note that the public system is very supportive of long-term therapy. However, many emphasize that enrolling in social security is a slow, bureaucratic process for newcomers.